A team of international researchers, led by UC San Francisco, has completed the first large-scale study of posterior cortical atrophy, a baffling constellation of visuospatial symptoms that present as the first symptoms of Alzheimer’s disease.
Exclusive: SR One raises $200M+ for third fund, still with GSK support
SR One, a life sciences venture capital firm that years ago split from GSK, has raised more than $200 million for a growth opportunities fund,